Hemp Industry News

Linton back in cannabis business as chairman, investor and adviser

Ousted Canopy Growth co-CEO Bruce Linton is getting back into the marijuana business in a big way, resurfacing as a senior executive, investor and adviser in three separate companies in the U.S. and Canada. Linton is joining Michigan-based Gage Cannabis Co. as executive chairman, parent company Wolverine Partners said Tuesday. Gage said in a release […]

Read More

MJBizDaily awards deadline is Saturday for cannabis leaders

The deadline for submitting nominations for Marijuana Business Daily’s inaugural MJBizDaily Awards is Saturday. The awards, which will be held during MJBizCon Week (Dec. 7-13) in Las Vegas, will recognize the top companies, individuals and organizations participating in the global cannabis industry. The MJBizDaily editorial staff will choose the winners in the awards categories that cover different […]

Read More

Week in Review: Weedmaps to end its ads for illicit cannabis, FBI probes MJ industry, MO licensing odds & more

Weedmaps plans to cease advertising unlicensed cannabis retailers, the FBI looks into public corruption in the legal marijuana industry, Missouri receives more than 2,000 medical marijuana applications – and more of the week’s top cannabis business news. Weedmaps to stop advertising unlicensed businesses The influential marijuana site Weedmaps, which is one of the most popular […]

Read More

Week in Review: Louisiana medical marijuana kickoff, Dixie-Arizona Iced Tea team, NM reciprocity & more

Sales begin in the long-delayed Louisiana medical marijuana market, MJ-infused product brand Dixie signs a licensing deal with Arizona Iced Tea’s parent, a New Mexico judge’s ruling could open MMJ sales to out-of-state patients – and more of the week’s top cannabis business news. MMJ sales begin down on the bayou After years of waiting, […]

Read More

How to avoid fantasy valuations in cannabis

Visions dance in the heads of key players of entire aisles in grocery stores and pharmacies dominated by marijuana and hemp products. Behind that, of course, there are visions of dynastic wealth.

Read More

‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker

Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London’s GW Pharma (Nasdaq: GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales and new patient enrollments since the […]

Read More

Canadian cannabis firm Cronos spending $300 million to enter US hemp market

Cronos Group, a vertically integrated cannabis company based in Ontario, Canada, that has international production and distribution, said Friday it will buy four operating subsidiaries from Redwood Holding Group for $300 million. Redwood, which is headquartered in Los Angeles, produces, markets and distributes hemp-derived CBD products, including skin care, bath items and gummies, throughout the […]

Read More

Week in Review: US Congress mulls milestone cannabis bills, on-premise MJ edibles moves in Alaska & more

A milestone U.S. marijuana reform bill is introduced in Congress, experts suggest cannabis banking changes at the federal level remain a long shot, Alaska’s capital city approves an ordinance permitting customers to consume cannabis edibles inside licensed retail establishments – and more of the week’s top marijuana business news. Key member of U.S. House introduces sweeping cannabis […]

Read More